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Low 
Prevalence
Significant  
Morbidity
Evidence suggests 
this is not 
happening
11.8% GP and 9.7% 
pharmacists 
identified BRONJ as a 
side effect of 
bisphosphonates4
17% of patients on 
oral bisphosphonate 
identified BRONJ as a 
side effect5
72% of participants reported no 
cooperation between physicians 
and dentists6
62% of physicians not 
requesting oral health 
care by a dentist before 
bisphosphonate therapy6
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Introduction
Method
Results
A multidisciplinary approach to the prevention of MRONJ is recommended in 
the literature for the management of patients prescribed implicated medicines, 
incorporating both patient and health professional education of the risk of the 
development of MRONJ1,2,3
Medication related osteonecrosis of the jaw (MRONJ), is a rare adverse effect of 
anti-resorptive or anti-angiogenic drug therapy that can cause significant 
morbidity; commonly prescribed drugs such as bisphosphonates have been 
associated with MRONJ.1
1-1 semi-structured interviews following a Grounded Theory methodology 
were used throughout this research7 with concurrent collection and analysis of 
qualitative data and constant comparison between participants.
Recruitment via 3 National Institute for Health Research Clinical Research 
Networks (NIHR CRNs); North East and North Cumbria, Yorkshire and Humber, 
and North Thames.
Three distinct groups were recruited to the study;
1.Patients with a diagnosis of MRONJ.
2.Patients prescribed oral bisphosphonates,
3.Patients with a diagnosis of osteoporosis not currently undergoing drug 
treatment
Interviews were audio recorded and transcribed verbatim. Ritchie and 
Spencer’s Framework Analysis (2002)8 allowed salient themes to be identified 
from the data. 
A total of 23 patients were included in this study. In depth semi-structured
interviews were carried out between May 2017 and March 2018 until no
more new themes emerged.
Four salient inter-related themes emerged from the data:
(1) Quality of life – physical, psychological and social impact of MRONJ
“This is difficult, but mentally, it gives you some kind of anxiety because
you- you know your bone is there-a little piece of bone on your left-hand
side is there and then you think, maybe perhaps in the future, you need to
have an operation. It’s a big operation.” (MRONJ 5)
(2) Perceived knowledge – limited awareness of the condition, risk factors
or preventative strategies
They didn’t explain about (on prescribing) anything about any side-effects
or anything about trouble with your teeth. (B-6)
I was given no information about that (risk of MRONJ)…Doctors don’t tell
you about the side-effects of drugs. (MRONJ-6)
(3) Interprofessional management – perceived organisation hierarchy,
professional roles and responsibilities, articulation of risk and
communication
I think they (Drs) should be able to provide the risks and the benefit and
discuss with the patient what’s probably be-best with them. I don’t think
this is done very well. (MRONJ-6)
I feel as though the pharmacist that I go to, I could ask her anything and she
would tell us. I have had a review with her, she’s very, very helpful and
knowledgeable about medication (B-5)
(4) Wider context – demands on NHS resources and barriers to dental care
You have to pay for the examination and then obviously, depending on the
amount of work that you need, that can be quite expensive. And not
everybody has that money. (B-6)
Comparison with existing literature
Our previous qualitative study of general medical practitioners and 
pharmacists in England9 produced similar findings with limited knowledge 
of both professional groups mirrored in that of the patients interviewed 
during this study.
Masson (2009) identified that only 11.8% of GMPs and 9.7% of pharmacists 
advised patients to inform their dentist they were using a bisphosphonate.4
The patients interviewed in this study also highlighted a lack of information 
from prescribers and pharmacists with most patients getting the 
information from the patient information leaflet. 
A small quantitative study of 34 patients with MRONJ utilising the Oral 
Health Impact Profile (OHIP-14) found that the condition significantly 
(p<0.001) affects quality of life.10 This study, along with the findings of this 
research, has highlighted the issues faced by patients and the ongoing 
physical and psychological distress associated with MRONJ.
Future work and implications for clinical practice
The importance of preventative measures should be stressed to all
healthcare professionals managing this particular patient group.
The perspectives of dental professionals on how the professions can
collaborate to improve patient care, would be important to consider before
implementing any preventative strategies
Further exploration of the role of the pharmacist in the interprofessional
team and integration of oral health services should be considered. The
MUR and NMS service specification does not currently include
bisphosphonates; inclusion could provide an opportunity for
reinforcement of preventative advice during the initiation stages of
treatment with bisphosphonates.
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